Article Versions Notes

Mikhel IB, Bakhrushina EO, Petrusevich DA, Nedorubov AA, Appolonova SA, Moskaleva NE, Demina NB, Kosenkova SI, Parshenkov MA, Krasnyuk II Jr., et al. Development of an Intranasal In Situ System for Ribavirin Delivery: In Vitro and In Vivo Evaluation. Pharmaceutics. 2024; 16(9):1125. https://doi.org/10.3390/pharmaceutics16091125

Mikhel, Iosif B., Elena O. Bakhrushina, Danila A. Petrusevich, Andrey A. Nedorubov, Svetlana A. Appolonova, Natalia E. Moskaleva, Natalia B. Demina, Svetlana I. Kosenkova, Mikhail A. Parshenkov, Ivan I. Krasnyuk, Jr., and et al. 2024. "Development of an Intranasal In Situ System for Ribavirin Delivery: In Vitro and In Vivo Evaluation" Pharmaceutics 16, no. 9: 1125. https://doi.org/10.3390/pharmaceutics16091125

Mikhel, I. B., Bakhrushina, E. O., Petrusevich, D. A., Nedorubov, A. A., Appolonova, S. A., Moskaleva, N. E., Demina, N. B., Kosenkova, S. I., Parshenkov, M. A., Krasnyuk, I. I., Jr., & Krasnyuk, I. I. (2024). Development of an Intranasal In Situ System for Ribavirin Delivery: In Vitro and In Vivo Evaluation. Pharmaceutics, 16(9), 1125. https://doi.org/10.3390/pharmaceutics16091125